Chemist Warehouse has raised investor expectations of bumper earnings growth and big margins ahead of its expected listing on the ASX, reporting sales of more than $5 billion in the last six months of 2024.

The retailing giant will shake up the market when it completes its merger with Sigma Healthcare, with brokers expecting the combined company to move into the S&P/ASX 50 index when it begins trading next month.